Ardelyx (FRA:41X) Beginning Cash Position : €37.7 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ardelyx Beginning Cash Position?

Ardelyx's Beginning Cash Position for the quarter that ended in Sep. 2024 was €37.7 Mil.

Ardelyx's quarterly Beginning Cash Position increased from Mar. 2024 (€19.8 Mil) to Jun. 2024 (€33.6 Mil) and increased from Jun. 2024 (€33.6 Mil) to Sep. 2024 (€37.7 Mil).

Ardelyx's annual Beginning Cash Position declined from Dec. 2021 (€80.6 Mil) to Dec. 2022 (€68.4 Mil) but then increased from Dec. 2022 (€68.4 Mil) to Dec. 2023 (€88.2 Mil).

Ardelyx Beginning Cash Position Historical Data

The historical data trend for Ardelyx's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ardelyx Beginning Cash Position Chart

Ardelyx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

70.89

148.89

80.56

68.37

88.16

Ardelyx Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial															28.17	30.96	19.75	33.58	37.74

Ardelyx Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Ardelyx Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Ardelyx's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ardelyx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ardelyx Inc (FRA:41X) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ARDX:USA 41X:Germany

Address

400 Fifth Avenue, Suite 210, Waltham, MA, USA, 02451

Website

https://www.ardelyx.com

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Ardelyx Headlines

No Headlines